Safety of New Formulation of Glatiramer Acetate (Song)

- Relapsing Remitting Multiple Sclerosis
- Completed

Study Title: Safety of New Formulation of Glatiramer Acetate

Teva Identifier: PM033

ClinicalTrials.gov Identifier: NCT00947752

Study Status: Completed

Trial Condition(s): Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Glatiramer Acetate | Drug: Experimental Glatiramer Acetate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: 07/01/2009 - 11/01/2009

Phase: Phase 3

Study Type

Interventional